Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/18/2005CA2279898C Elastomer treatment process to decrease peroxide levels
10/18/2005CA2264588C Solid foamed active substance preparations
10/18/2005CA2242646C Amino acid composition
10/18/2005CA2240728C Kappa agonist compounds and pharmaceutical formulations thereof
10/18/2005CA2238389C Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
10/18/2005CA2218054C Solid compositions containing polyethylene oxide and an active ingredient
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/18/2005CA2152507C Novel combination of benzoquinazoline antifolates and protecting agents
10/18/2005CA2148928C Pharmacologically active pyridine derivatives and processes for the preparation thereof
10/18/2005CA2137441C Amino-substituted benzenesulfonylureas and -thioureas, processes for their preparation, and their use as pharmaceuticals
10/18/2005CA2132544C Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/18/2005CA2046265C Sulphured imadazole derivatives, their preparation process, the new intermediates obtained, their application as drugs and the pharmaceutical preparations containing them
10/18/2005CA2033640C Vaccines against cancer and infectious diseases
10/15/2005CA2504551A1 Process for the preparation of adsorbates of valsartan and/or its solvates or hydrates
10/15/2005CA2504255A1 The local administration of a combination of sirolimus and 2-methoxyestradiol for the treatment of vulnerable plaque
10/15/2005CA2464687A1 Spirastrellolides, antimitotic macrolides and analogues; and pharmaceutical compositions and research tools thereof
10/13/2005WO2005095959A2 Methods for treating dermatological conditions in a patient
10/13/2005WO2005095613A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095566A1 Compositions containing interestified lipids and phytosterol ester, and related methods, with health and nutrition promoting characteristics
10/13/2005WO2005095494A1 Novel water-soluble fullerene, process for producing the same and active oxygen generator containing the fullerene
10/13/2005WO2005095464A1 Hyaluronic acid/methotrexate compound
10/13/2005WO2005095463A1 Modified pectins, compositions and methods related thereto
10/13/2005WO2005095450A2 Therapeutic use of a growth factor, nsg33
10/13/2005WO2005095440A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
10/13/2005WO2005095438A1 Saponins, the preparation and the use of the same
10/13/2005WO2005095436A1 Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia
10/13/2005WO2005095429A1 Phenol derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095427A1 Composition for prevention or treatment of thrombosis
10/13/2005WO2005095425A1 Dithiophosphato-platinum-complexes for the treatment of cancers
10/13/2005WO2005095420A1 Novel thiazolopyrazoles and methods of their use
10/13/2005WO2005095419A1 Thiazolopyrimidine derivative
10/13/2005WO2005095417A1 Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
10/13/2005WO2005095416A1 Process for producing flavone c glycoside derivatives
10/13/2005WO2005095414A1 Adiponectin increasing agent
10/13/2005WO2005095413A1 Antitumor agent
10/13/2005WO2005095412A1 Antiallergic agent
10/13/2005WO2005095411A1 Furochromene derivative with anti-inflammatory activity
10/13/2005WO2005095407A1 M3 muscarinic acetylcholine receptor antagonists
10/13/2005WO2005095406A1 Compositions useful as inhibitors of protein kinases
10/13/2005WO2005095403A2 Macrocyclic compounds as inhibitors of viral replication
10/13/2005WO2005095402A1 Substituted 1,4,8-triazaspiro[4.5]decan-2-on compounds for use in the treatment of obesity
10/13/2005WO2005095401A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005WO2005095399A2 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
10/13/2005WO2005095397A1 Tetrahydropyridoindole derivatives
10/13/2005WO2005095389A1 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
10/13/2005WO2005095386A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005WO2005095383A1 Heterocyclic cgrp antagonists for the treatment of migraine
10/13/2005WO2005095382A1 Anti-tumor agent
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095378A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005WO2005095376A1 Antiviral agents
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095373A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095372A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095369A1 Water soluble esters of [n-(4-amino-2-butynyl)] with anticancer activity
10/13/2005WO2005095368A1 Thiadiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095365A1 Oxazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095364A1 Phenoxyacetic acid derivative and medicine containing the same
10/13/2005WO2005095363A1 Bicyclic compound and medicine containing the same
10/13/2005WO2005095362A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
10/13/2005WO2005095361A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005095359A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005WO2005095356A1 Agent for generating heat or singlet oxygen and composition for cancer treatment each comprising organic peroxide or chemiluminescent compound
10/13/2005WO2005095353A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005WO2005095350A1 Pyrazole compounds and uses related thereto
10/13/2005WO2005095349A1 Crystalline pyrazole derivative
10/13/2005WO2005095348A2 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication
10/13/2005WO2005095341A1 Nitrogen-containing heterocyclic compound
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095333A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/13/2005WO2005095330A1 Novel dichloropropene derivatives
10/13/2005WO2005095328A1 Chemical process and new crystalline form
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005095324A1 Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
10/13/2005WO2005094918A1 Solid pharmaceutical preparation for dialysis
10/13/2005WO2005094901A1 Formulations and methods to prepare inhalable buffered methacholine chloride solutions.
10/13/2005WO2005094899A1 Clusterin antisense therapy for treatment of cancer
10/13/2005WO2005094896A2 Targeted serotonin reuptake inhibitors
10/13/2005WO2005094895A1 Production and use of the methotrexate-albumin conjugate as an immunosuppressive agent in gvhd
10/13/2005WO2005094892A1 Nutritional product
10/13/2005WO2005094888A1 Damaged tissue therapeutic agent and therapeutic method
10/13/2005WO2005094885A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
10/13/2005WO2005094878A1 Composition having antitumor effect
10/13/2005WO2005094869A1 Compositions and methods for improved mucus function
10/13/2005WO2005094864A2 Treatment of hedgehog- and wnt-secreting tumors with inhibitors of lipoprotein particle biogenesis
10/13/2005WO2005094858A1 Antidiabetic composition
10/13/2005WO2005094854A1 Modified nutraceutical composition
10/13/2005WO2005094851A1 Water-soluble fraction extracted from animal organ, method of producing the same, reverse transcription inhibitor, reverse transcriptase inhibitor, viral growth inhibitor and medicinal compositions
10/13/2005WO2005094843A1 Rapidly disintegrating taste-masked tablet
10/13/2005WO2005094842A1 Vitamin b12-containing compositions and methods of use
10/13/2005WO2005094841A1 Use of adenosine for treating complications of surgery
10/13/2005WO2005094840A1 Compositions comprising mannose phosphate for vaginal treatment
1 ... 4503 4504 4505 4506 4507 4508 4509 4510 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 4522 4523 ... 7860